The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis
Open accessAbstract
Cellular metabolism is increasingly recognized as a controller of immune cell fate and function. MicroRNA-33 (miR-33) regulates cellular lipid metabolism and represses genes involved in cholesterol efflux, HDL biogenesis, and fatty acid oxidation. Here, we determined that miR-33-mediated disruption of the balance of aerobic glycolysis and mitochondrial oxidative phosphorylation instructs macrophage inflammatory polarization and shapes innate and adaptive immune responses. Macrophage-specific Mir33 deletion increased oxidative respiration, enhanced spare respiratory capacity, and induced an M2 macrophage polarization-associated gene profile. Furthermore, miR-33-mediated M2 polarization required miR-33 targeting of the energy sensor AMP-activated protein kinase (AMPK), but not cholesterol efflux. Notably, miR-33 inhibition increased macrophage expression of the retinoic acid-producing enzyme aldehyde dehydrogenase family 1, subfamily A2 (ALDH1A2) and retinal dehydrogenase activity both in vitro and in a mouse model. Consistent with the ability of retinoic acid to foster inducible Tregs, miR-33-depleted macrophages had an enhanced capacity to induce forkhead box P3 (FOXP3) expression in naive CD4(+) T cells. Finally, treatment of hypercholesterolemic mice with miR-33 inhibitors for 8 weeks resulted in accumulation of inflammation-suppressing M2 macrophages and FOXP3(+) Tregs in plaques and reduced atherosclerosis progression. Collectively, these results reveal that miR-33 regulates macrophage inflammation and demonstrate that miR-33 antagonism is atheroprotective, in part, by reducing plaque inflammation by promoting M2 macrophage polarization and Treg induction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several studies have found that antagonism of miR-33 can reduce atherosclerotic plaque burden (Karunakaran et al., 2015; Ouimet et al., 2015; Rayner et al., 2011b; Rotllan et al., 2013).”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Ouimet et al., 2015
In the citing paper
“Inhibition of miR-33a or miR-33a deletion in macrophages has been shown to affect myeloid cell differentiation 25) , induce M2 macrophage polarization with mitochondrial respiratory and metabolic changes 26 , 27) , and enhance autophagy 28 , 29) .”
From Critical Role of microRNA-33a/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives (2026) · cites this paper as [26]
In the citing paper
“Expression of miR-33 is also overexpressed in M1, thus promoting pro-inflammatory functions [132].”
From MicroRNAs as Regulators of Phagocytosis (2022) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 3×
“In addition, macrophages play important roles in tissue homeostasis and resolution of inflammation (2).”
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Self-citationMacrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Self-citationMetabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 1×
“…malonyl-CoA–mediated inhibition of CPT1 and stimulating uptake of activated fatty acids into the mitochondria (44, 45), and (b) enhancement of expression of SIRT1 and PGC-1 α , resulting in transcriptional activation of genes involved in mitochondrial FAO and mitochondrial biogenesis (46, 47).”
Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 395
Reduced miR-181d level in obesity and its role in lipid metabolism via regulation of ANGPTL3
Abu‐Farha, M., Cherian, P., Al‐Khairi, I., Nizam, R., Alkandari, A., Arefanian, H., Tuomilehto, J., Al‐Mulla, F., & Abubaker, J. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-48371-2 · Cited by 30
Macrophage miRNAs in atherosclerosis
Karunakaran, D., & Rayner, K. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.006 · Cited by 29
Self-citationWang, H., Hu, Z.-B., Shi, F., Dong, J., Dang, L., Wang, Y., Sun, Z., Zhou, H., Zhang, S., Cao, X.-S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0210-5 · Cited by 28
Interaction between lipid metabolism and macrophage polarization in atherosclerosis
Wang, X., Xie, Z., Zhang, J., Chen, Y., Li, Q., Yang, Q., Xu, C., Liu, B., Xu, S., & Dong, Y. (2025) · iScience · doi:10.1016/j.isci.2025.112168 · Cited by 28
Qiu, Y., Xu, J., Yang, L., Zhao, G., Ding, J. X., Chen, Q., Zhang, N., Yang, R., Wang, J., Li, S., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112507 · Cited by 28
Chen, R., Xie, F., Zhao, J., & Yue, B. (2020) · Respiratory Research · doi:10.1186/s12931-020-01391-3 · Cited by 28
Deng, C., Xiao, Y., Zhao, X., Li, H., Chen, Y., Ai, K., Jiang, T., Wei, J., Chen, X. S., Lei, G., et al. (2025) · Advanced Science · doi:10.1002/advs.202411911 · Cited by 29
Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders
López-Pedrera, C., Barbarroja, N., Patiño-Trives, A. M., Luque-Tévar, M., Torres-Granados, C., Aguirre, M. A., Collantes‐Estévez, E., & Pérez‐Sánchez, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062012 · Cited by 28
MicroRNAs as Regulators of Phagocytosis
Gierlikowski, W., & Gierlikowska, B. (2022) · Cells · doi:10.3390/cells11091380 · Cited by 25
Henderson, J., Pryzborski, S., Stratton, R. J., & O’Reilly, S. (2020) · Experimental Dermatology · doi:10.1111/exd.14136 · Cited by 25
Macrophage SUCLA2 coupled glutaminolysis manipulates obesity through AMPK
Peng, C., Jiang, H., Jing, L., Yang, W., Guan, X., Wang, H., Yu, S., Cao, Y., Wang, M., Ma, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57044-w · Cited by 26
Lin, N., & An, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5121 · Cited by 23
Koyama, S., Horie, T., Nishino, T., Baba, O., Sowa, N., Miyasaka, Y., Kuwabara, Y., Nakao, T., Nishiga, M., Nishi, H., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012609 · Cited by 23
The role of exosomes in the tumour microenvironment on macrophage polarisation
Wang, J., Long, R., & Han, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188811 · Cited by 24
The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease
Huang, X. J., Zeng, Z., Li, S., Xie, Y., & Tong, X. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122760 · Cited by 25
Immunometabolism in atherosclerotic disorders
Fleetwood, A. J., Noonan, J. E., Gruta, N. L. L., Kallies, A., & Murphy, A. J. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00473-5 · Cited by 28
Emodin: Its role in prostate cancer‑associated inflammation (Review)
Tu, Y., Wu, Z., Tan, B., Yang, A., & Fang, Z. (2019) · Oncology Reports · doi:10.3892/or.2019.7264 · Cited by 22
Szydełko, J., & Matyjaszek-Matuszek, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010616 · Cited by 19
Recent Developments in Delivery of MicroRNAs Utilizing Nanosystems for Metabolic Syndrome Therapy
Li, T., Zhu, L., Zhu, L., Wang, P., Xu, W., & Huang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157855 · Cited by 23
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression
Fernández-Tussy, P., Cardelo, M. P., Zhang, H., Sun, J., Price, N. L., Boutagy, N. E., Goedeke, L., Cadena-Sandoval, M., Xirouchaki, C. E., Brown, W., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.168476 · Cited by 21
Functional Regulation of Macrophage Phenotypes by MicroRNAs in Inflammatory Arthritis
Niu, X., & Schulert, G. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02217 · Cited by 23
MicroRNA-33 Inhibits Adaptive Thermogenesis and Adipose Tissue Beiging
Afonso, M. S., Verma, N., van Solingen, C., Cyr, Y., Sharma, M., Perie, L., Corr, E. M., Schlegel, M., Shanley, L. C., Peled, D., et al. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.315798 · Cited by 21
Self-citationJiang, Q., Li, Y., Wu, Q., Huang, L., Xu, J., & Zeng, Q. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.01.001 · Cited by 21
Interplay between miRNAs and Mycobacterium tuberculosis: diagnostic and therapeutic implications
Singh, A. K., Ghosh, M., Kumar, V., Aggarwal, S. S., & Patil, S. A. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.021 · Cited by 22
Multipathway Regulation for Targeted Atherosclerosis Therapy Using Anti-miR-33-Loaded DNA Origami
Ma, Y., Wang, Q., Du, S., Luo, J., Sun, X., Jia, B., Ge, J., Dong, J., Jiang, S., & Li, Z. (2024) · ACS Nano · doi:10.1021/acsnano.3c10213 · Cited by 20
Costa, V., Carina, V., Raimondi, L., Luca, A. D., Bellavia, D., Conigliaro, A., Salamanna, F., Alessandro, R., Fini, M., & Giavaresi, G. (2019) · Cells · doi:10.3390/cells8121495 · Cited by 20
Implications for MicroRNA involvement in the prognosis and treatment of atherosclerosis
Tabaei, S., & Tabaee, S. S. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03992-4 · Cited by 21
Macrophage fatty acid oxidation in atherosclerosis
Xiao, S., Qi, M., Zhou, Q., Gong, H.-Q., Wei, D., Wang, G., Feng, Q., Wang, Z., Liu, Z., Zhou, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116092 · Cited by 25
Regulatory T cells and macrophages in atherosclerosis: from mechanisms to clinical significance
Ouyang, X., & Liu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1435021 · Cited by 20
The miR-23-27-24 clusters drive lipid-associated macrophage proliferation in obese adipose tissue
Sprenkle, N. T., Winn, N. C., Bunn, K. E., Zhao, Y., Park, D. J., Giese, B. G., Karijolich, J. J., Ansel, K. M., Serezani, C. H., Hasty, A. H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112928 · Cited by 19
Mitochondrial Melatonin: Beneficial Effects in Protecting against Heart Failure
Reiter, R. J., Sharma, R., Chuffa, L. G. D. A., Šimko, F., & Domínguez‐Rodríguez, A. (2024) · Life · doi:10.3390/life14010088 · Cited by 19
Cai, J., Huang, J., Li, D., Zhang, X., Shi, B., Liu, Q., Fang, C. R., Xu, S., & Zhang, Z. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.005 · Cited by 19
Mallat, Z. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309730 · Cited by 19
Zhu, Y., Fan, S., Lu, Y., Yan, W., Tang, J., Yang, Y., Li, F., Chen, Q., Zheng, J., & Liu, X. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.03.001 · Cited by 19
The role of ALDHs in lipid peroxidation-related diseases
Wang, Y.-N., & Liu, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138760 · Cited by 18
The power of microRNA regulation—insights into immunity and metabolism
Oliveto, S., Manfrini, N., & Biffo, S. (2025) · FEBS Letters · doi:10.1002/1873-3468.70039 · Cited by 21
Salloum, Z., Lehoux, E. A., Harper, M., & Catelas, I. (2020) · Journal of Orthopaedic Research® · doi:10.1002/jor.24758 · Cited by 19
Wilson, H. M. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220441 · Cited by 18
Guo, Y., Huang, S., Ma, Y., Zhang, J., Wen, Y., Zhou, L., Yuan, G., & Cheng, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109332 · Cited by 18
Song, M., Xu, S., Zhong, A., & Zhang, J. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.03.001 · Cited by 18
Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure
Sansonetti, M., & Windt, L. J. D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab192 · Cited by 17
Qian, Z., Yang, H., Li, H., Liu, C., Yang, L., Qu, Z., & Li, X. (2021) · Biomedicines · doi:10.3390/biomedicines9091150 · Cited by 17
Kowara, M., Borodzicz-Jażdżyk, S., Rybak, K., Kubik, M., & Cudnoch‐Jędrzejewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115718 · Cited by 17
Geng, X., Mao, G., Zhao, D.-M., Xiang, Y., Wang, M., Guo, Y., & Tan, L. (2022) · Placenta · doi:10.1016/j.placenta.2022.03.011 · Cited by 17
miRNAs and High-Density Lipoprotein metabolism
Baldán, Á., & Vallim, T. Q. D. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.021 · Cited by 18
Collura, S., Morsiani, C., Vacirca, A., Fronterrè, S., Ciavarella, C., Vasuri, F., D’Errico, A., Franceschi, C., Pasquinelli, G., Gargiulo, M., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101090 · Cited by 17
Li, R., Shen, C., Tao, Y., Zhang, X.-F., Zhang, Q., Ma, Z., & Wang, Z. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.043 · Cited by 16
MicroRNA in cardio-metabolic disorders
Su, X., Nie, M., Zhang, G., & Wang, B. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.03.024 · Cited by 18
Emerging roles of microRNAs in the metabolic control of immune cells
Yao, Q., Song, Z., Wang, B., & Zhang, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.024 · Cited by 17
Conditional Deoxyribozyme–Nanoparticle Conjugates for miRNA-Triggered Gene Regulation
Zhang, J., Ma, R., Blanchard, A. T., Petree, J. R., Jo, H., & Salaita, K. S. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c07609 · Cited by 16
Chen, Y., Lu, F., Zhang, Z., Li, X., Zhang, R., & Zheng, T. (2025) · Virulence · doi:10.1080/21505594.2025.2573660 · Cited by 15
Liu, H., Wu, S., Lee, H., Baudo, G., Massaro, M., Zhang, A., Hamilton, D. J., & Blanco, E. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202100232 · Cited by 15
Global research trends in atherosclerosis: A bibliometric and visualized study
Tian, W., Zhang, T., Wang, X., Zhang, J., Ju, J., & Xu, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.956482 · Cited by 18
Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr −/− mice
Zhao, L., Cozzo, A. J., Johnson, A., Christensen, T., Freemerman, A. J., Bear, J. E., Rotty, J. D., Bennett, B. J., & Makowski, L. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.009 · Cited by 15
Song, K., Li, L., Sun, G., & Wei, Y.-J. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5947 · Cited by 15
LeBlond, N. D., Ghorbani, P., O’Dwyer, C., Ambursley, N., Nunes, J. R. C., Smith, T. K. T., Trzaskalski, N. A., Mulvihill, E. E., Viollet, B., Foretz, M., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120001040 · Cited by 15
Self-citationNon-Coding RNAs in the Crosstalk between Breast Cancer Cells and Tumor-Associated Macrophages
Benedetti, A., Turco, C., Fontemaggi, G., & Fazi, F. (2022) · Non-Coding RNA · doi:10.3390/ncrna8010016 · Cited by 16
Ma, F., Li, T., Zhang, H.-J., & Wu, G.-J. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000419 · Cited by 13
Multiple roles of ALDH1 in health and disease
Zhao, W., Xia, Y., Gao, Z., Chen, J., & Zhang, E. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1627164 · Cited by 14
Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis
Miyagawa, S., Horie, T., Nishino, T., Koyama, S., Watanabe, T., Baba, O., Yamasaki, T., Sowa, N., Otani, C., Matsushita, K., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202301902 · Cited by 14
Myeloid-Specific Deletion of the AMPKα2 Subunit Alters Monocyte Protein Expression and Atherogenesis
Fißlthaler, B., Zippel, N., Malik, R. A., Lagos, F. D., Zukunft, S., Thoele, J., Siuda, D., Soehnlein, O., Wittig, I., Heidler, J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123005 · Cited by 13
Pinos, I., Yu, J., Pilli, N. R., Kane, M. A., & Amengual, J. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159291 · Cited by 13
Retinoids in Mammalian Reproduction, with an Initial Scoping Effort to Identify Regulatory Methods
Nilsson, C. B. (2020) · TemaNord · doi:10.6027/temanord2020-507 · Cited by 13
β-Carotene accelerates the resolution of atherosclerosis in mice
Pinos, I., Coronel, J., Albakri, A., Blanco, A., McQueen, P., Molina, D., Sim, J., Fisher, E. A. A., & Amengual, J. (2023) · eLife · doi:10.7554/elife.87430 · Cited by 18
Self-citationFuentevilla-Álvarez, G., Soto, M. E., Robles-Herrera, G. J., Vargas-Alarcón, G., Sámano, R., Meza-Toledo, S., Huesca-Gómez, C., & Gamboa, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137078 · Cited by 12
Yamasaki, T., Horie, T., Koyama, S., Nakao, T., Baba, O., Kimura, M., Sowa, N., Sakamoto, K., Yamazaki, K., Obika, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16017-5 · Cited by 13
Crosstalk Between Cholesterol, ABC Transporters, and PIP2 in Inflammation and Atherosclerosis
Gulshan, K. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-21547-6_13 · Cited by 12
Non-coding RNA regulation of T cell biology: Implications for age-associated cardiovascular diseases
Coelho‐Lima, J., & Spyridopoulos, I. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.014 · Cited by 13
Wang, L., Rohatgi, A. P., & Wan, Y. Y. (2020) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2020.02.009 · Cited by 12
Impact of noncoding RNAs on cancer directed immune therapies: Now then and forever
Roy, R. K., Yadav, R., Sharma, U., Wasson, M. K., Sharma, A. K., Tanwar, P., Jain, A., & Prakash, H. (2022) · International Journal of Cancer · doi:10.1002/ijc.34060 · Cited by 13
Aldehyde dehydrogenase 1 family: A potential molecule target for diseases
Duan, X., Hu, H., Wang, L., & Chen, L. (2024) · Cell Biology International · doi:10.1002/cbin.12188 · Cited by 11
Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia
Mosakhani, N., Missiry, M. E., Vakkila, E., Knuutila, S., & Vakkila, J. (2017) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000921 · Cited by 12
Baba, O., Horie, T., Nakao, T., Hakuno, D., Nakashima, Y., Nishi, H., Kuwabara, Y., Nishiga, M., Nishino, T., Ide, Y., et al. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00604-17 · Cited by 12
Metabolomics in cancer and cancer-associated inflammatory cells
dos Santos, G. C., Saldanha-Gama, R. F. G., de Brito, N. M., Renovato‐Martins, M., & Barja‐Fidalgo, C. (2021) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.86 · Cited by 12
Tasopoulou, K.-M., Argiriou, C., Tsaroucha, A. K., & Georgiadis, G. S. (2023) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2023.02.029 · Cited by 11
Schlegel, M., Cyr, Y., Newman, A. A. C., Schreyer, K. F., Durán, J. G. B., Sharma, M., Bozal, F. K., Gourvest, M., Forest, M. L., Afonso, M. S., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412690121 · Cited by 12
Self-citationSevoflurane preconditioning protects from posttransplant injury in mouse lung transplantation
Yamada, Y., Laube, I., Jang, J., Bonvini, J. M., İnci, İ., Weder, W., Beck‐Schimmer, B., & Jungraithmayr, W. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.03.021 · Cited by 11
Sun, Q., Yang, X., Qin, H., Zhang, W., Wang, J., Ning, Y., & Dong, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108873 · Cited by 11
Qiu, H., Shen, L., Shen, Y. H., & Mao, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1096911 · Cited by 12
The Link between miRNAs and PCKS9 in Atherosclerosis
Mačvanin, M., Gluvic, Z. M., Klisic, A. N., Manojlovic, M. S., Suri, J. S., Rizzo, M., & Isenović, E. R. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673262124231102042914 · Cited by 13
Non-coding RNAs in aneurysmal aortopathy
Spin, J. M., Li, D. Y., Mäegdefessel, L., & Tsao, P. S. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.06.008 · Cited by 13
Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions
Guo, Y., Luo, F., Yi, Y., & Xu, D. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0381-6 · Cited by 11
Liu, C., Pan, X., Hao, Z., Wang, X., Wang, C., & Song, G. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12615 · Cited by 11
MicroRNA-mediated metabolic regulation of immune cells in cancer: an updated review
Khameneh, S. C., Razi, S., Lashanizadegan, R., Akbari, S., Sayaf, M., Haghani, K., & Bakhtiyari, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1424909 · Cited by 10
Trained immunity in diabetes: emerging targets for cardiovascular complications
Bai, Y., Wu, J., & Jian, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1533620 · Cited by 12
Winski, G., Chernogubova, E., Busch, A., Eken, S. M., Jin, H. H., Liljeqvist, M. L., Khan, T., Bäcklund, A., Paloschi, V., Roy, J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00892-w · Cited by 12
Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages
Li, J., Lu, Z., Zhang, Y., Xia, L., & Su, Z. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.02.003 · Cited by 10
Very low HDL levels: clinical assessment and management
Bonilha, I., Luchiari, B., Nadruz, W., & Sposito, A. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000585 · Cited by 12
Molecular Mechanisms Underlying Atherosclerosis and Current Advances in Targeted Therapeutics
Zhu, B. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020634 · Cited by 11
New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis
Vellozo, N. S., Rigoni, T. S., & Lopes, M. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.704429 · Cited by 10
Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism
Baldán, Á., & Fernandez-Hernando, C. F. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000358 · Cited by 9
Monocytic microRNAs—Novel targets in atherosclerosis therapy
Euler, G., & Parahuleva, M. S. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16367 · Cited by 9
Smith, T. K. T., Ghorbani, P., LeBlond, N. D., Nunes, J. R. C., O’Dwyer, C., Ambursley, N., Fong-McMaster, C., Minarrieta, L., Burkovsky, L. A., El-Hakim, R., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117608 · Cited by 9
Self-citationNon-coding RNAs in lipid metabolism and their roles in atherosclerosis
Sallam, T., Solingen, C. V., & Moore, K. J. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01229-9 · Cited by 8
Self-citationLipid metabolic alterations in cancer: Common pathophysiology with cardiovascular disease
Llena-Meler, M., Canfrán‐Duque, A., Madrigal‐Matute, J., & Rotllán, N. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.01.003 · Cited by 12
miR-33-3p Regulates PC12 Cell Proliferation and Differentiation In Vitro by Targeting Slc29a1
Shan, B., Li, W., He, H., Zhao, H., Tian, M.-L., Cheng, X., Qin, J., & Jin, G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03377-z · Cited by 8
Feng, X., Yang, C., Wang, T., Zhang, J., Zhou, H., Ma, B., Xu, M., & Deng, G. (2025) · Cells · doi:10.3390/cells14020087 · Cited by 8
Emerging Roles for Immune Cells and MicroRNAs in Modulating the Response to Cardiac Injury
Rodriguez, A. M., & Yin, V. P. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6010005 · Cited by 8
Jeong, S., Jun, J. H., Kim, J. Y., Park, H. J., Cho, Y., & Kim, G. J. (2021) · Biomedicines · doi:10.3390/biomedicines9080920 · Cited by 8
A host lipase prevents lipopolysaccharide-induced foam cell formation
Feng, J., Jiang, W., Cheng, X., Zou, B., Varley, A. W., Liu, T., Qian, G., Zeng, W., Tang, J., Zhao, Q., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103004 · Cited by 8
Metadata
- Authors
- Ouimet, M., Ediriweera, H. N., Gundra, U. M., Sheedy, F. J., Ramkhelawon, B., Hutchison, S. B., Rinehold, K., van Solingen, C., Fullerton, M. D., Cecchini, K., Rayner, K. J., Steinberg, G. R., Zamore, P. D., Fisher, E. A., Loke, P., & Moore, K. J.
- Affiliations
- New York University (US)
- University of Ottawa (CA)
- Howard Hughes Medical Institute (US)
- McMaster University (CA)
- NYU Langone Health (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2015-10-26
- Volume
- 125
- Issue
- 12
- Pages
- 4334-4348
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4665799
- OpenAlex
- W2123366371
- Cited by
- 394
- References
- 67
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 27 · 2023: 37 · 2022: 24 · 2021: 45 · 2020: 45 · 2019: 46 · 2018: 35 · 2017: 47 · 2016: 33 · 2015: 1
- FWCI
- 19.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association (14POST20180018, 15POST25090199)
- NYU Langone Medical Center (P30CA016087)
- Canada Research Chairs
- National Institutes of Health (UL1TR000038, TR000038)
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (R01HL084312, HL-084312, HL098055, P01HL098055, R01HL119047, R01HL108182, T32HL098129)
- National Cancer Institute (P30CA016087)
- National Institute of Allergy and Infectious Diseases (R21AI094166, R01AI093811, R01AI094166, T32AI007180)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- microRNA-33, macrophage polarization, M2 macrophages, atherosclerosis, aerobic glycolysis, mitochondrial oxidative phosphorylation, AMPK, ALDH1A2, retinoic acid, regulatory T cells, Foxp3, plaque inflammation, hypercholesterolemia, atheroprotection, lipid metabolism
- MeSH terms
- Aldehyde Dehydrogenase 1 Family, Aldehyde Dehydrogenase, Animals, Gene Expression Regulation, Glycolysis, Oxygen Consumption, Macrophages, Peritoneal, Mice, Knockout, MicroRNAs, Atherosclerosis, T-Lymphocytes, Regulatory, Retinal Dehydrogenase, Mice, Forkhead Transcription Factors, AMP-Activated Protein Kinases, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review